gxpclinic | Pharmaceutical Regulatory Consulting — QP · RP · RPi · Auditing · Training

Pharmaceutical Compliance
You Can Rely On

Expert QP, RP, and RPi services. Inspection readiness and GxP auditing for manufacturers, importers, and wholesalers across the United Kingdom and European Union.

QP Services RP & RPi GMP Audits GDP Compliance Inspection Ready
Scroll
✓
MHRA Registered
UK regulatory compliance
🇪🇺
EU GMP Compliant
EMA & national CA expertise
📋
GMP & GDP Auditor
First-, second- & third-party
⚙
ICH Q10 QMS Expert
Quality management systems
⚡
Rapid Response
Available within 48 hours

Regulatory Expertise.
Real-World Experience.

gxpclinic was founded by Dr. Raffaele Misul to give pharmaceutical businesses access to senior-level regulatory expertise without the overhead of a full-time headcount.

MHRA Approved
HPRA Approved
AIFA Approved
EU GMP Compliant
ICH Q10 Expert

Bridging Compliance and Innovation

With roots in large pharma and specialist contract organisations, Dr. Misul has held QP, RP, and Head of Quality positions across oral solid dosage, biologics, ATMP, and sterile product manufacturing. He understands what regulators look for because he has sat in both chairs.

For over three decades, gxpclinic has served clients navigating the unique dual-framework reality of post-Brexit pharmaceutical regulation.

  • 30+ years in pharmaceutical quality and regulatory affairs
  • Qualified Person registered with MHRA and EU national authorities
  • Expert in GMP, GDP, and pharmaceutical quality systems
  • Extensive experience with MHRA, EMA, and competent authority inspections
  • Advisor to pharmaceutical manufacturers, importers, and wholesalers
Meet the Founder

Dr. Raffaele Misul

Founder, CEO & Principal Consultant at gxpclinic. A seasoned pharmaceutical professional with a PhD in Pharmaceutical Sciences and over 30 years of hands-on industry experience.

From batch certification to full QMS overhauls, Dr. Misul has guided companies through the most challenging regulatory landscapes with a 100% inspection success rate.

Dr. Raffaele Misul
Dr. Raffaele Misul
Founder, CEO & Principal Consultant
PhD Pharmaceutical Sciences
30+ Years Industry Experience
GMP & GDP Specialist
Regulatory Affairs Expert
30+
Years in Pharma

Expert Services for a
Regulated Industry

From QP batch release to full inspection preparation, we provide the regulatory expertise pharmaceutical companies need to stay compliant and competitive.

UK & EU

Qualified Person (QP) Services

Contractual QP services for manufacturers, importers, and MAH holders. We handle batch certification, QP declarations, and Annex 16 responsibilities.

  • Batch certification and release under UK & EU GMP
  • Annex 16 QP declarations for imported medicinal products
  • QP oversight of contract manufacturing organisations (CMOs)
  • Site readiness for MIA and MIA(IMP) licensing
  • QP gap analysis and remediation plans
Request QP Services →
GDP / WDA(H)

Responsible Person (RP) for Wholesalers

Named and deputy RP services for wholesale dealers holding or applying for WDA(H) licences, ensuring full compliance with MHRA expectations and EU GDP.

  • Named RP and deputy RP appointments
  • WDA(H) licence applications and variations
  • GDP SOP development and annual review
  • Supplier and customer qualification programmes
  • Temperature excursion management and recalls
Request RP Services →
Post-Brexit Specific

Responsible Person (Import) — RPi

A role unique to post-Brexit UK. As your RPi, we take formal responsibility for verifying that imported finished products meet UK GMP requirements before release.

  • RPi designation under UK MIA licence conditions
  • Post-Brexit import testing waiver applications
  • Supply chain verification from EU and third countries
  • GMDP certificate verification and site qualification
  • MIA(IMP) variation and renewal support
Request RPi Services →
MHRA / EMA

Inspection Readiness & Auditing

Comprehensive preparation for regulatory inspections from MHRA, EMA, and EU national competent authorities. Mock inspections, gap analysis, and CAPA.

  • Mock MHRA and competent authority inspections
  • Pre-inspection gap analysis against current GMP/GDP guidelines
  • CAPA management and verification of effectiveness
  • First-, second-, and third-party GxP audits
  • Annual product review (APR) and quality metrics support
Request Audit Services →
Quality Systems

Quality Management Systems

Design, implementation, and maintenance of pharmaceutical quality systems aligned with ICH Q10. Practical, inspection-ready documentation.

  • QMS design and SOP authoring aligned to ICH Q10
  • Change control, deviation, and CAPA systems
  • Validation master plans and CSV/CSA programmes
  • Training programmes and qualification frameworks
  • Self-inspection programme development and execution
Request QMS Support →
Advisory

Regulatory Strategy & Advisory

Strategic guidance for pharmaceutical companies navigating UK and EU regulatory complexity post-Brexit, through product launches and site transfers.

  • Post-Brexit regulatory strategy for UK vs EU divergence
  • Licence applications, variations, and renewals
  • Technical due diligence for M&A and site acquisitions
  • Regulatory intelligence and horizon scanning
  • Expert witness and dispute support services
Request Advisory →
Training

GxP Training

Bespoke training programmes for staff at all levels. From induction to advanced GMP/GDP modules, delivered on-site or remotely.

Induction Advanced On-site Remote
Global

Regulatory Affairs

Strategic regulatory support for MA applications, variations, renewals, and post-authorisation commitments across the UK and EU.

MA Applications Variations UKCA CE Marking
Quality Risk

Risk Assessment & FMEA

Systematic risk assessment for pharmaceutical operations. FMEA, risk-based decision making, and quality risk management aligned with ICH Q9 principles.

FMEA Risk Assessment ICH Q9 QRM
Commercial

Commercial Brand & Generic Pharma

End-to-end regulatory support for commercial pharmaceutical products. Batch release, market authorisation maintenance, and lifecycle management for branded and generic medicines.

Batch Release MA Maintenance Generics Lifecycle
Clinical

IMP & NPP Services

Specialised QP and regulatory support for Investigational Medicinal Products and Named Patient Programmes. MIA(IMP) compliance, importation, and clinical trial supply chain oversight.

MIA(IMP) Clinical Trials Named Patient CT-3
View Published Paper →

From First Call to
Ongoing Partnership

A structured, efficient engagement model built around your timelines and regulatory obligations.

01

Initial Scoping Call

Free 30-minute call to understand your compliance requirements, timelines, and the specific regulatory context — UK, EU, or both.

02

Proposal & Agreement

Tailored proposal with clear scope, deliverables, and fees. Service agreements drafted to reflect your specific licence and operational model.

03

Onboarding & Gap Analysis

Structured review of your current quality system, documentation, and compliance posture. Gap analysis report with prioritised action plan.

04

Active Compliance Support

Ongoing QP, RP, or RPi services with defined SLAs. Monthly reporting, CAPA tracking, and direct availability for urgent regulatory matters.

UK & EU. Two Frameworks.
One Team.

Post-Brexit pharmaceutical regulation means operating under two distinct legal frameworks simultaneously. Our consultants hold credentials and practical experience in both — no handoffs, no gaps.

We provide seamless regulatory coverage across the United Kingdom, European Union, and third-country supply chains.

🇬🇧
United Kingdom
MHRA, HRA, VMD — MIA, WDA(H), MIA(IMP). Full UK GMP/GDP framework including post-Brexit divergence from EU Annex 16.
🇪🇺
European Union
EMA, national CAs including HPRA, PEI, AIFA, ANSM. EU GMP Annex 1–21, GDP guidelines, Eudralex Vol. 4.
🌐
Third Country Supply
Import QP and RPi services for products manufactured in USA, India, China, Switzerland — MRA and BTWP navigation.
🧬
Advanced Therapies
ATMP, biologics, and cell & gene therapy GMP compliance under EU Regulation 1394/2007 and UK ATMPs framework.
Regulatory Frameworks
UK
UK GMP — The Rules for Good Manufacturing Practice
Human Medicines Regulations 2012 and the UK version of Eudralex Vol. 4, maintained by MHRA post-Brexit.
UK
MHRA GDP — Guidance on Wholesale Distribution
UK-specific GDP guidelines covering WDA(H) holders and the role of the Responsible Person.
EU
EU GMP — Eudralex Volume 4
Commission Directive 2003/94/EC, Annexes 1–20 including the revised sterile manufacturing Annex 1 (2022).
EU
EU GDP — Guidelines 2013/C 343/01
Good Distribution Practice including temperature monitoring, qualification, and traceability.
UK + EU
ICH Guidelines Q8–Q12
Pharmaceutical development, quality risk management, pharmaceutical quality systems.

Your Next Inspection
Should Not Be a Surprise

Whether you need an experienced QP tomorrow or want to build long-term compliance infrastructure, we are ready to support you. First consultation is always free.

Let's Talk Compliance

Whether you have an urgent regulatory matter or are planning ahead, we respond to all enquiries within one business day.

Contact Information

Our London office serves as the hub for our UK and European operations. We are available for on-site engagements across the continent.

Address
United Kingdom
Availability
Mon – Fri: 08:00 – 18:00 GMT/BST. Urgent matters: 24/7 via email.